Dietary Supplement Censure May Be Based On "Significant" Risk - Henney
This article was originally published in The Tan Sheet
Executive Summary
Regulatory actions against dietary supplements based on evidence of "significant risk" may be appropriate when the exact degree of risk cannot be determined, Jane Henney, MD, states in Sept. 15 written responses to questions posed by Senate Labor & Human Resources Committee Chairman James Jeffords (R-Vt.).
You may also be interested in...
Dietary Supplement GMPs Could Lean Toward Drug Model, Troy Hints
FDA's proposed rule on dietary supplement Good Manufacturing Practices could more closely follow the pharmaceutical GMPs model than would be preferred by the supplement industry
Dietary Supplement GMPs Could Lean Toward Drug Model, Troy Hints
FDA's proposed rule on dietary supplement Good Manufacturing Practices could more closely follow the pharmaceutical GMPs model than would be preferred by the supplement industry
Dietary Supplement GMPs Could Lean Toward Drug Model, Troy Hints
FDA's proposed rule on dietary supplement Good Manufacturing Practices could more closely follow the pharmaceutical GMPs model than would be preferred by the supplement industry